Page last updated: 2024-10-29

iohexol and Cognition Disorders

iohexol has been researched along with Cognition Disorders in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cronqvist, SE1
Holtås, SL1
Laike, T1
Ozolins, A1
Ratcliff, G1
Sandler, S1
Latchaw, R1

Trials

1 trial available for iohexol and Cognition Disorders

ArticleYear
Psychic changes following myelography with metrizamide and iohexol. A comparative investigation with psychologic tests.
    Acta radiologica: diagnosis, 1984, Volume: 25, Issue:5

    Topics: Cognition Disorders; Contrast Media; Double-Blind Method; Drug Evaluation; Female; Humans; Intervert

1984

Other Studies

1 other study available for iohexol and Cognition Disorders

ArticleYear
Cognitive and affective changes after myelography: a comparison of metrizamide and iohexol.
    AJR. American journal of roentgenology, 1986, Volume: 147, Issue:4

    Topics: Adult; Cognition Disorders; Female; Humans; Iodobenzoates; Iohexol; Male; Metrizamide; Middle Aged;

1986